Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

吉利德科学公司（Gilead Sciences）与LEO Pharma日前宣布达成战略合作伙伴关系，共同加速LEO Pharma的小分子口服STAT6项目的开发和商业化，旨在为炎症性疾病患者提供潜在治疗方案。

Taiwan Coast Guard says ship that allegedly cut cable crewed by Chinese Request To Download Free Sample of This Strategic Report @ ...

Shareholders request Human Rights Due Diligence to determine whether pharma companies do everything they can to increase drug ...

A statement from Gilead indicates that the deal is likely to lower its 2025 GAAP and non-GAAP earnings per share by $0.15 to ...

The colorful picture book is helping parents of young children deal with the difficult journey that follows a breast cancer ...

Gilead Sciences Inc (NASDAQ: GILD) is strongly positioned to “change the face of HIV” in 2025, according to its chairman and ...

Gilead’s investment will let it assess the therapeutic potential of targeting STAT6, a transcription factor involved in IL-4 ...